Jerome H. Kim, M.D., is an international expert on the development and evaluation of vaccines and is the Director General of the International Vaccine Institute (IVI), whose mission is to discover, develop and deliver safe, effective and affordable vaccines for Global Health. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease. IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is in Phase III testing with regulatory approval expected in 2021. IVI is collaborating on vaccines against COVID-19 from different companies and in different stages of development, from laboratory to post-emergency use approval. Prior to IVI, he was the Principal Deputy, US Military HIV Research Program; Chief, Laboratory of Molecular Virology and Pathogenesis; and led the Army’s Phase III HIV vaccine trial that showed efficacy in the prevention of HIV-1. Dr. Kim is an Adjunct Professor, Department of Medicine, Uniformed Services University and at the Graduate School of Public Health, Yonsei University. He has authored over 300 publications.

He is a graduate of the University of Hawaii, with high honors in History and highest honors in Biology, and received his M.D. from the Yale University School of Medicine.